ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Pumpkin Pie Turmeric Breakfast Smoothie - Vegan + Gluten-Free

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Vitamin D supplementation extends life in mouse model of Huntington's disease

Omega-3 fatty acid stops known trigger of lupus

Conquer Your Email Inbox, Increase Productivity and Reduce Stress

The Significance of Selenium

Print Page
Email Article

Study Suggests That Inflammation May Play a Role in Developing High Blood Pressure

  [ 68 votes ]   [ Discuss This Article ] • December 9, 2003

High levels of C-reactive protein are associated with an increased risk of developing high blood pressure, according to an article in the December 10 issue of The Journal of the American Medical Association (JAMA).

Increased levels of C-reactive protein are associated with chronic activation of the immune system, otherwise known as an inflammatory response, according to background information in the article. High C-reactive protein levels have also been linked to an increase risk of heart attack and stroke. Because of this association, some researchers believe that hypertension (high blood pressure) may be in part an inflammatory disorder.

Howard D. Sesso, Sc.D., M.P.H., of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues examined whether C-reactive protein levels were associated with hypertension.

The researchers studied 20,525 women who participated in the Women's Health Study, which started in 1992. Women participating in this study were 45 years or older at the beginning of the study, and had normal blood pressures (systolic blood pressure less than 140 mm Hg; diastolic blood pressure less than 90 mm Hg). Blood samples collected at the beginning of the study were used to measure C-reactive protein levels. Women were followed up for a median of 7.8 years (half the women were followed up longer than 7.8 years, half were followed up less than 7.8 years) for the development of hypertension.

Over the follow-up period, 5,365 women developed high blood pressure. The researchers found that "Overall, there was a positive association between increasing levels of C-reactive protein and risk of developing hypertension," the authors write. Participants with the highest levels of C-reactive protein measured at the beginning of the study were about twice as likely to develop hypertension.

"This study provides evidence that baseline levels of C-reactive protein are modestly but independently associated with an increased risk of incident hypertension, even among those with very low initial [blood pressures]," the authors write. "This finding for C-reactive protein was independent of baseline levels of [blood pressure]. Similar effects were observed among those participants without baseline coronary risk factors and in analyses where C-reactive protein was considered a continuous variable. These data suggest that inflammation may have a potentially important role in the development of hypertension," the authors conclude. (JAMA. 2003;290:2945-2951. Available post-embargo at

Editor's Note: This study was supported by research grants from the National Institutes of Health (Bethesda, Md.), a Scientist Development grant from the American Heart Association (Dallas), with additional support from Pharmacia Inc., the Doris Duke Foundation (New York, N.Y.), the Donald W. Reynolds Foundation (Las Vegas), and the Leducq Foundation (Paris). Co-author Paul M. Ridker, M.D., M.P.H., is named as a co-inventor on patents filed by the Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease and is a Donald W. Reynolds Investigator and receives additional support from the Doris Duke Charitable Foundation and the Leducq Foundation.


In an accompanying editorial, Scott M. Grundy, M.D., Ph.D., of the University of Texas Southwestern Medical Center, Dallas, discusses the link found by Sesso et al between inflammation (as evidenced by high levels of C-reactive protein) and hypertension, and notes a similar association between low-grade inflammation and metabolic syndrome. "[Metabolic syndrome] consists of a clustering of several metabolic components in one individual," writes Dr. Grundy, including obesity, and dyslipidemia (disorders of lipoprotein metabolism, which includes high cholesterol levels).

Dr. Grundy writes that "Sesso et al did not specifically address the question of what proportion of individuals with high-normal levels of C-reactive protein actually met criteria for the metabolic syndrome," but "nonetheless, the present demonstration of an apparent connection between low-grade inflammation and hypertension supports the concept that elevated blood pressure should be listed as one of the components of the metabolic syndrome."

Dr. Grundy also notes that more research is needed to explain the relationship between inflammatory markers like C-reactive protein, the metabolic syndrome and cardiovascular and arterial disease. (JAMA. 2003;290:3000-3002. Available post-embargo at

Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Ultra EPA  - Fish Oil Vitamin D3 Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Enhance Eyelashes Naturally Enhance Eyelashes Naturally
Safely Burn Away Body Fat Safely Burn Away Body Fat
Curcumin - a Golden Gift of Nature with Benefits Still Untold Curcumin - a Golden Gift of Nature with Benefits Still Untold
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS
Reversing Neurodegeneration with a New Magnesium Compound Reversing Neurodegeneration with a New Magnesium Compound

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map